New Key Statistics Module, Z-Score and F-Score
NAS:RLAY Key Ratios
| Market Cap $ M | 964.01 |
| Enterprise Value $ M | 326.69 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.41 |
| Price/Sales | 25.53 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 35.00 |
| EPS (TTM) $ | -2.52 |
| Beneish M-Score | 28.96 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -5.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.87 |
| EV-to-EBITDA | -0.89 |
| PEG | -- |
| Shares Outstanding M | 133.89 |
| Net Margin (%) | -916.92 |
| Operating Margin % | -1,060.46 |
| Pre-tax Margin (%) | -916.92 |
| Quick Ratio | 15.64 |
| Current Ratio | 15.64 |
| ROA % (ttm) | -37.30 |
| ROE % (ttm) | -42.84 |
| ROIC % (ttm) | -442.48 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.21 |
RLAY Number of Guru Trades
RLAY Volume of Guru Trades
Gurus Latest Trades with NAS:RLAY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RLAY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Relay Therapeutics Inc Insider Transactions
No Available Data
News about NAS:RLAY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers